Novavax’s latecomer COVID-19 vaccine is dragging in its uptake levels as more than 97 percent of the nation’s supply hasn’t been administered yet, CDC data shows.
Read the full post on Becker's Hospital Review - Healthcare News
Mere 2.3% of Novavax’s vaccine has been used
